Currently we test and support the following browsers:
St. Jude Children’s Research Hospital scientists find mechanism that launches production of the specialized T cells essential for combating infectious agents and that offers new therapeutic possibilities. (Dr. Hongbo Chi)
St. Jude Children’s Research Hospital–Washington University Pediatric Cancer Genome Project study identifies drugs that enhance oxidative stress as possible weapon against most common pediatric soft tissue tumor. (Dr. Michael Dyer)
St. Jude Children’s Research Hospital scientists identify enzyme that could lead to better diagnosis and treatment of Alzheimer’s disease and related disorders. (Dr. Alessandra d'Azzo)
St. Jude Children’s Research Hospital scientists report that avian H2N2 influenza A viruses related to 1957-1958 pandemic infect human cells and spread among ferrets; may aid identification of emerging threats. (Dr. Robert Webster)
St. Jude Children’s Research Hospital study finds that young adults who had cancer as children are more likely to be frail than their peers; this condition leaves survivors at increased risk of death and chronic disease. (Dr. Kirsten Ness)
St. Jude Children’s Research Hospital leads study showing that a drug withdrawn from the market in 2010 may enhance the effectiveness of bone marrow transplants for select pediatric leukemia patients. (Dr. Jeffrey Rubnitz)
James R. Downing, M.D., becomes hospital’s sixth IOM member
Study led by St. Jude Children’s Research Hospital finds an inherited gene variation—more common among Hispanic Americans–is tied to increased risk of developing a high-risk form of pediatric leukemia. (Dr. Jun Yang)
A study led by St. Jude Children’s Research Hospital identifies new path to a universal influenza vaccine emphasizing production of broadly specific antibodies that target multiple flu viruses. (Dr. Maureen McGargill)
A Childhood Cancer Survivors Study led by St. Jude Children’s Research Hospital suggests that reducing risk factors like hypertension might lower the risk of heart disease for survivors as they age. (Dr. Greg Armstrong)
Robyn Diaz, J.D., tapped to serve as chief legal officer and senior vice president.
Charles J. Sherr, M.D., Ph.D., to receive the Prize for Scientific Excellence in Medicine by the American-Italian Cancer Foundation.
Larry Kun, M.D., to oversee all aspects of patient care and clinical services at the hospital.
St. Jude Children’s Research Hospital investigators prove that an immune marker predicts transplant success and improves selection of bone marrow donors (Dr. Wing Leung)
Dr. William E. Evans will retire from executive post in July 2014.
Research from St. Jude Children’s Research Hospital, Memorial Sloan-Kettering Cancer Center and the University of Washington identifies a mutation that predisposes individuals to most common form of childhood leukemia. (Dr. Charles Mullighan)
The St. Jude Children’s Research Hospital-led national BABY HUG trial linked hydroxyurea to a 21 percent reduction in annual medical costs for young children with sickle cell anemia; savings expected to grow. (Dr. Winfred Wang)
At St. Jude, doctors and scientists work to improve childhood cancer survival rates as well as enhance patients’ long-term quality of life after treatment.
After identifying a protein that blocks death of high-risk acute lymphoblastic leukemia (ALL) cells, scientists use two-drug combination therapy to offer hope to children and adults with the disease. (Dr. Joseph Opferman)
Study strengthens link between amyotrophic lateral sclerosis (ALS) and problems in protein production machinery of cells and identifies possible treatment strategy. (Dr. J. Paul Taylor)
St. Jude Children’s Research Hospital study yields clues for designing next-generation drugs to treat autoinflammatory diseases. (Dr. Kanneganti)
St. Jude Children’s Research Hospital researchers discover how to unleash the immune system against cancer in model system without triggering autoimmune reactions. (Dr. Dario Vignali)
The Donald Pinkel Endowed Chair of Pediatric Cancer Treatment honors first director of St. Jude and is among the largest endowed chairs in the nation.
St. Jude Children’s Research Hospital discovers a role for a protein in research that has implications for treatment of cancer and heart disease. (Dr. Joseph Opferman)
St. Jude Children’s Research Hospital study challenges prior understanding of the process regulating specialized T cells that are essential for a balanced immune system. (Dr. Hongbo Chi)
Andres Herrada, Ph.D., a postdoctoral fellow in the Department of Immunology at St. Jude Children’s Research Hospital, has been named a Pew Latin American Fellow in the Biomedical Sciences by The Pew Charitable Trusts.
St. Jude Children’s Research Hospital study identifies the need for proactive, life-long medical follow-up and provides the most complete health picture yet of adult survivors of childhood cancer. (Dr. Melissa Hudson)
A study led by St. Jude Children’s Research Hospital shows epigenetic changes that turn genes on and off are as unique as alterations in DNA and may be as important in causing the most common childhood cancer. (Dr. Charles Mullighan)
James M. Hoffman, Pharm.D., medication outcomes and safety officer at St. Jude Children’s Research Hospital, has been named a fellow by the American Society of Health-System Pharmacists (ASHP) for excellence in pharmacy practice.
Virologist Robert G. Webster, Ph.D., of St. Jude Children’s Research Hospital, is the recipient of the Charles Mérieux Award from the National Foundation for Infectious Diseases (NFID).
St. Jude Children’s Research Hospital ranks first on the list of places top students and young professionals want to work, according to a survey conducted by the National Society of High School Scholars (NSHSS).
Michael Dyer, Ph.D., of St. Jude Children's Research Hospital, has been recognized as one of the nation’s leading biomedical researchers by the Howard Hughes Medical Institute.
St. Jude Children’s Research Hospital advances understanding of how T cells craft an appropriate immune response; setting the stage for new strategies to intervene if the system goes awry. (Dr. Dario Vignali)
St. Jude Children’s Research Hospital scientist named to honorary society.
St. Jude Children’s Research Hospital and the CERN Foundation host event to bring attention to a rare brain tumor that strikes both children and adults
The St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project advances understanding of genetic defects underlying childhood low-grade gliomas and identifies promising new drug therapies. (Dr. David Ellison)
Charles Sherr, M.D., Ph.D., of St. Jude Children’s Research Hospital, is honored by the AACR Academy for his scientific contributions to advancing understanding and treatment of cancer.
St. Jude Children’s Research Hospital plays key role in research showing that drug shortages erode the quality and increase the cost of cancer care; experts warn that shortages persist despite efforts to fix the problem. (Dr. James Hoffman)
The United States Patent and Trademark Office today awarded St. Jude Children’s Research Hospital U.S. patent number 8,399,645 for St. Jude’s invention of compositions for genetically modifying human immune cells so they can destroy some of the most common forms of cancer in children and adults.
Study links inherited genetic variations in a few genes to increased risk of acute lymphoblastic leukemia (ALL) and helps to explain ethnic differences in the cancer’s incidence. (Dr. Jun J. Yang)
St. Jude Children’s Research Hospital ties mutations in two genes to the death of motor neurons associated with ALS, or Lou Gehrig's disease, and other devastating neurodegenerative problems. (J. Paul Taylor, MD, PhD)
St. Jude Children’s Research Hospital-led analysis finds rise less than in previous years; cancer drugs the exception. (James Hoffman, PharmD)
St. Jude Children’s Research Hospital has been named one of the best cancer care hospitals in the country by Parents magazine. The results, based on the magazine’s survey of more than 60 children’s hospitals, appear in the March 2013 issue.
St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project takes new approach to measuring the repetitive DNA at the end of chromosomes and opens new window on mechanisms fueling cancer. (Jinghui Zhang, PhD)
St. Jude Children’s Research Hospital scientists lead a study that finds new genetic defects in high-risk childhood leukemia subtypes with chromosomal loss and evidence that some patients have an inherited cancer syndrome. (Charles Mullighan, MBBS(Hons), MSc, MD)
St. Jude Children’s Research Hospital has been recognized for the third consecutive year by FORTUNE magazine as one of the “100 Best Companies to Work For.”